The application of the micronucleus test in Chinese hamster V79 cells to detect drug-induced photogenotoxicity

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 445, Issue 1, 1999, Pages 55-71

  Kersten, B ^a   Zhang, J ^a   Brendler Schwaab, S Y ^b   Kasper, P ^a   Muller L ^a  

^a Fed Inst Drugs and Med Devices   (Germany)

^b Toxicology   (Germany)

Author keywords

8 methoxypsoralen; Doxycycline; Emodin; Fluoroquinolone; Griseofulvin; Hypericin; Met ronidazole; Oxytetracycline; Phenothiazine; Photo micronucleus test; Photochemical genotoxicity; Photochemical toxicity; Photosensitizer; UV light

Indexed keywords

BAY 3118; CHLORPROMAZINE; DOXYCYCLINE; EMODIN; GREPAFLOXACIN; GRISEOFULVIN; HYPERICIN; LOMEFLOXACIN; METHOXSALEN; METRONIDAZOLE; OXYTETRACYCLINE; PHENOTHIAZINE DERIVATIVE; PHOTOSENSITIZING AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIFLUPROMAZINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CARCINOGENESIS; CHINESE HAMSTER; GENOTOXICITY; MICRONUCLEUS TEST; NONHUMAN; PHOTOTOXICITY; PRIORITY JOURNAL; RELIABILITY; ULTRAVIOLET RADIATION;

ANIMALS; ANTI-INFECTIVE AGENTS; CELL LINE; CRICETINAE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; EMODIN; FLUOROQUINOLONES; GRISEOFULVIN; METHOXSALEN; METRONIDAZOLE; MICRONUCLEUS TESTS; PERYLENE; PHENOTHIAZINES; PHOTOSENSITIZING AGENTS; TETRACYCLINES; ULTRAVIOLET RAYS;

EID: 0032874967     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00143-6     Document Type: Article

References (56)

1. Martinez L.J., Li G., Chignell C.F. Photogeneration of fluoride by the fluoroquinolone antimicrobial agents lomefloxacin and fleroxacin. Photochem. Photobiol. 65:1997;599-602.
2. Hirose M., Wakabayashi K., Grivas S., De Flora S., Arakawa N., Nagao M., Sugimura T. Formation of a nitro derivative of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline by photo-irradiation. Carcinogenesis. 11:1990;869-871.
3. de Mol N.J., Beijersbergen van Henegouwen G.M.J., van Beele B. Singlet oxygen formation by sensitization of furocoumarins complexed with, or bound covalently to DNA. Photochem. Photobiol. 34:1981;661-666.
4. Emerit I. Reactive oxygen species, chromosome mutation, and cancer: possible role of clastogenic factors in carcinogenesis. Free Radical Biol. Med. 16:1994;99-109.
5. Umezawa N., Arakane K., Ryu A., Mashiko S., Hirobe M., Nagano T. Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. Arch. Biochem. Biophys. 342:1997;275-281.
6. Yu T.-W., Anderson D. Reactive oxygen species-induced DNA damage and its modification: a chemical investigation. Mutat. Res. 379:1997;201-210.
7. Nataraj A.J., Black H.S., Ananthaswamy H.N. Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7961-7965.
8. Klecak G., Urbach F., Urwyler H. Fluoroquinolone antibacterials enhance UVA-induced skin tumors. J. Photochem. Photobiol. B: Biol. 37:1997;174-181.
9. Loveday K.S. Interrelationship of photocarcinogenicity, photomutagenicity and phototoxicity. Photochem. Photobiol. 63:1996;369-372.
10. Müller L., Kasper P. The relevance of photomutagenicity testing as a predictor of photocarcinogenicity. Int. J. Toxicol. 17:1998;551-558.
11. Loprieno N. In vitro assay systems for testing photomutagenic chemicals. Mutagenesis. 6:1991;331-333.
12. Dean S.W., Lane M., Dunmore R.H., Ruddock S.P., Martin C.N., Kirkland D.J., Loprieno N. Development of assays for the detection of photomutagenicity of chemicals during exposure to UV-light: I. Assay development. Mutagenesis. 6:1991;335-341.
13. Utesch D., Splittgerber J. Bacterial photomutagenicity testing: distinction between direct, enzyme-mediated and light-induced events. Mutat. Res. 361:1996;41-48.
14. Chételat A.A., Albertini S., Dresp J.H., Strobel R., Gocke E. Photomutagenesis test development: I. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in bacterial and yeast assays. Mutat. Res. 292:1993;241-250.
15. Chételat A.A., Albertini S., Gocke E. The photomutagenicity of fluoroquinolones in tests for gene mutation, chromosomal aberration, gene conversion and DNA breakage (Comet assay). Mutagenesis. 11:1996;497-504.
16. Uggla A.H., Sundell-Berman S. The induction and repair of DNA damage detected by the DNA precipitation assay in Chinese hamster ovary cells treated with acridine orange+visible light. Mutat. Res. 236:1990;119-127.
17. Laquerbe A., Moustacchi E., Papadopoulo D. Genotoxic potential of psoralen cross-links versus monoadducts in normal human lymphoblasts. Mutat. Res. 346:1995;173-179.
18. Noodt B.B., Kvam E., Steen H.B., Moan J. Primary DNA damage, HPRT mutation and cell inactivation photoinduced with various sensitizers in V79 cells. Photochem. Photobiol. 58:1993;541-547.
19. Chételat A.A., Dresp J.H., Gocke E. Photomutagenesis test development: II. 8-Methoxypsoralen, chlorpromazine and sunscreen compounds in chromosomal aberration assays using CHO cells. Mutat. Res. 292:1993;251-258.
20. Youssefi A.A., Arutyunyan R., Emerit I. Chromosome damage in PUVA-treated human lymphocytes is related to active oxygen species and clastogenic factors. Mutat. Res. 309:1994;185-191.
21. Stivala L.A., Pizzala R., Rossi R., Melli R., Verri M.G., Bianchi L. Photoinduction of micronuclei by 4,4′,6-trimethylangelicin and 8-methoxypsoralen in different experimental models. Mutat. Res. 327:1995;227-236.
22. Spielmann H., Balls M., Dupuis J., Pape W.J., Pechovitch G., deSilva O., Holzhutter H.G., Clothier R., Desolle P., Gerberick F., Liebsch M., Lovell W.W., Maurer T., Pfannenbecker U., Potthast J.M., Csato M., Sladowski D., Steiling W., Brantom P. The International EU/COLIPA In Vitro Phototoxicity Validation Study: results of phase II (blind trial): Part 1. The 3T3 NRU phototoxicity test. Toxicol. in Vitro. 12:1998;305-327.
23. Kalweit S., Utesch D., von der Hude W., Madle S. Chemically induced micronucleus formation in V79 cells - comparison of three different test approaches. Mutat. Res. 439:1999;183-190.
24. Seelbach A., Fissler B., Strohbusch A., Madle S. Development of a modified micronucleus assay in vitro for detection of aneugenic effects. Toxicol. in Vitro. 7:1993;185-193.
25. Miller B.M., Pujadas E., Gocke E. Evaluation of the micronucleus test in vitro using Chinese hamster cells: results of four chemicals weakly positive in the in vivo micronucleus test. Environ. Mol. Mutagen. 26:1995;240-247.
26. Vian L., Bichet N., Gouy D. The in vitro micronucleus test on isolated human lymphocytes. Mutat. Res. 291:1993;93-102.
27. Kirsch-Volders M. Towards a validation of the micronucleus test. Mutat. Res. 392:1997;1-4.
28. Van Hummelen P., Kirsch-Volders M. Analysis of eight known or suspected aneugens by the in vitro human lymphocyte micronucleus test. Mutagenesis. 7:1992;447-455.
29. Müller-Tegethoff K., Kersten B., Kasper P., Müller L. Application of the in vitro rat hepatocyte micronucleus assay in genetic toxicology testing. Mutat. Res. 392:1997;125-138.
30. Albertini S., Miller B., Chételat A.A., Locher F. Detailed data on in vitro MNT and in vitro CA: industrial experience. Mutat. Res. 392:1997;187-208.
31. Miller B., Pötter-Locher F., Seelbach A., Stopper H., Utesch D., Madle S. Evaluation of the in vitro micronucleus test as an alternative to the in vitro chromosomal aberration assay: position of the GUM working group on the in vitro micronucleus test. Mutat. Res. 410:1998;81-116.
32. Eastmond D.A., Pinkel D. Detection of aneuploidy and aneuploidy-inducing agents in human lymphocytes using fluorescence in situ hybridization with chromosome-specific DNA probes. Mutat. Res. 234:1990;303-318.
33. Kirsch-Volders M., Elhajouji A., Cundari E., Van Hummelen P. The in vitro micronucleus test: a multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat. Res. 392:1997;19-30.
34. Countryman P.I., Heddle J.A. The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat. Res. 41:1976;321-332.
35. Müller L., Kasper P., Kaufmann G. The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism. Mutat. Res. 282:1992;169-176.
36. Müller L., Kasper P., Kersten B., Zhang J. Photochemical genotoxicity and photochemical cacinogenesis - Two sides of a coin? Toxicol. Lett. 102-103:1998;383-387.
37. Stern R.S., Nichols K.T., Väkevä L.H. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). N. Engl. J. Med. 336:1997;1041-1045.
38. Santamaria L., Arnaboldi A., Andreoni L., Bianchi A., Daffara P. Photocarcinogenesis by methoxypsoralen, neutral red, proflavine, and long UV radiation. Cancer Detect. Prev. 8:1985;447-454.
39. Gasparro F.P., Liao B., Foley P.J., Wang X.M., McNiff J.M. Psoralen photochemotherapy, clinical efficacy, and photomutagenicity: the role of molecular epidemiology in minimizing risks. Environ. Mol. Mutagen. 31:1998;105-112.
40. Gocke E. Review of genotoxic properties of chlorpromazine and related phenothiazines. Mutat. Res. 366:1996;9-21.
41. K. Owen, A.B. Moult, M.N. Waldron, Lack of photocarcinogenicity of grepafloxacin compared to lomefloxacin and ciprofloxacin, Proc. of the 8th International Congress on Infectious Disease, International Society for Infectious Diseases, Boston, MA, 1998, pp. 231.
42. Domagala J.M. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J. Antimicrob. Chemother. 33:1994;685-706.
43. Rosen J.E., Chen D., Prahalad A.K., Spratt T.E., Schluter G., Williams G.M. A fluoroquinolone antibiotic with a methoxy group at the 8 position yields reduced generation of 8-oxo-7,8-dihydro-2′-deoxyguanosine after ultraviolet-A irradiation. Toxicol. Appl. Pharmacol. 145:1997;381-387.
44. Rosen J.E., Prahalad A.K., Schluter G., Chen D., Williams G.M. Quinolone antibiotic photodynamic production of 8-oxo-7,8-dihydro-2′-deoxyguanosine in cultured liver epithelial cells. Photochem. Photobiol. 65:1997;990-996.
45. Reavy H.J., Traynor N.J., Gibbs N.K. Photogenotoxicity of skin phototumorigenic fluoroquinolone antibiotics detected using the comet assay. Photochem. Photobiol. 66:1997;368-373.
46. Thoma K., Kerker R. Photoinstability of drugs - 1st communication on the behaviour of UV-absorbing drugs in daylight simulation. Pharm. Ind. 54:1992;169-177.
47. Godfrey R., Edwards R. A chromatographic and spectroscopic study of photodegraded metronidazole in aqueous solution. J. Pharm. Sci. 80:1991;212-218.
48. Kelly G.E., Meikle W.D., Moore D.E. Enhancement of UV-induced skin carcinogenesis by azathioprine: role of photochemical sensitisation. Photochem. Photobiol. 49:1989;59-65.
49. Smilack J.D., Wilson W.R., Cockerill F.R. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin. Proc. 66:1991;1270-1280.
50. Carpenter S., Fehr M.J., Kraus G.A., Petrich J.W. Chemiluminescent activation of the antiviral activity of hypericin: a molecular flashlight. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12273-12277.
51. Scaiano J.C. Mechanisms of singlet oxygen production by hypericin. Photochem. Photobiol. 68:1998;R3.
52. Ehrenberg B., Anderson J.L., Foote C.S. Kinetics and yield of singlet oxygen photosensitized by hypericin in organic and biological media. Photochem. Photobiol. 68:1998;135-140.
53. Vandenbogaerde A.L., Cuveele J.F., Proot P., Himpens B.E., Merlevede W.J., deWitte P.A. Differential cytotoxic effects induced after photosensitization by hypericin. J. Photochem. Photobiol. B: Biol. 38:1997;136-142.
54. Vandenbogaerde A.L., Delaey E.M., Vantieghem A.M., Himpens B.E., Merlevede W.J., deWitte P.A. Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem. Photobiol. 67:1998;119-125.
55. Vassileva S.G., Mateev G., Parish L.C. Antimicrobial photosensitive reactions. Arch. Intern. Med. 158:1998;1993-2000.
56. Glette J., Sandberg S. Phototoxicity of tetracyclines as related to singlet oxygen production and uptake by polymorphonuclear leukocytes. Biochem. Pharmacol. 35:1986;2883-2885.